URO-902

· Urovant Sciences GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for URO-902, covering 2023-04-20 to 2023-04-20. Get the full timeline:

Most recent: Clinical Trial Update: URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence [Phase 2]